Ocugen Inc. (NASDAQ:OCGN) finished Thursday with an addition of $0.13 to close at $1.26, an upside of 11.50 percent. An average of 4,742,360 shares of common stock have been traded in the last five days. There was a fall of -$0.0100 in the past week, and it reached a new high 1 time over the past 12 months. The last 20 days have seen an average of 4,708,980 shares traded, while the 50-day average volume stands at 4,476,062.
OCGN stock has decreased by -14.29% in the last month. The company shares reached their 1-month lowest point of $1.0900 on 12/28/22. With the stock rallying to its 52-week high on 01/03/22, shares of the company touched a low of $1.09 and a high of $5.06 in 52 weeks. It has reached a new high 1 time so far this year and lost -72.31% or -$3.2900 in price. In spite of this, the price is down -75.10% from the 52-week high.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
OCGN stock investors should be aware that Ocugen Inc. (OCGN) stock had its last reported insider trading activity 14 days ago on Dec 16. In this transaction, the insider spent $137,007. Chief Executive Officer, Musunuri Shankar, disposed of 100,000 shares at a price of $1.66 on Oct 14. The insider now owns more than $166,000 worth of shares. Prior to that, Director Kumar Ramesh went on to Sale 4,500 shares at $1.83 each on Oct 06. An amount of $8,235 was transacted.
Ocugen Inc. (OCGN) stock’s beta is 3.99. Other valuation ratios to consider include the price-to-book (PB) ratio at 2.86.
The quick ratio of Ocugen Inc. for the three months ended June 29 was 7.20, and the current ratio was 7.20, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.02 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $58.03 million.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Ocugen Inc.’s return on assets was -59.90%.
For the three-month period that ended June 29, Ocugen Inc. had $2.27 million in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$21.92 million in the quarter, while revenues of -$19.47 million were grew 50.91%. The analyst consensus anticipated Ocugen Inc.’s latest quarter earnings to come in at -$0.08 per share, but it turned out to be -$0.09, a -12.50% surprise. For the quarter, EBITDA amounted to -$22.98 million. Shareholders own equity worth $218.89 million.
From a technical analysis perspective, let’s take a brief look at Ocugen Inc. (OCGN) price momentum. RSI 9-day as of the close on 29 December was 43.55%, suggesting the stock is Neutral, with historical volatility in this time frame at 110.20%.
As of today, OCGN’s price is $1.2000 -0.79% or -$0.0100 from its 5-day moving average. OCGN is currently trading -19.23% lower than its 20-day SMA and -55.79% lower than its 100-day SMA. However, the stock’s current price level is -23.17% below the SMA50 and -53.51% below the SMA200.
The stochastic %K and %D were 16.17% and 13.14%, respectively, and the average true range (ATR) was 0.1170. With the 14-day stochastic at 32.08% and the average true range at 0.1170, the RSI (14) stands at 42.33%. The stock has reached -0.1067 on the 9-day MACD Oscillator while the 14-day reading was at -0.1812.
Mizuho launched coverage on Ocugen Inc. (NASDAQ: OCGN) in its analyst report released on August 23, 2022. The firm assigned the stock a Buy rating. The consensus rating for Ocugen Inc. (OCGN) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell OCGN, while 1 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 5 others rate it as a “buy”.
What is OCGN’s price target for the next 12 months?
Analysts predict a range of price targets between $3.50 and $8.00, with a median target of $5.00. Taking a look at these predictions, the average price target given by analysts for Ocugen Inc. (OCGN) stock is $5.33.